Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | Miles, D. | |
| dc.contributor.author | Pivot, X. | |
| dc.date.accessioned | 2017-01-30T11:01:12Z | |
| dc.date.available | 2017-01-30T11:01:12Z | |
| dc.date.created | 2014-11-19T01:13:19Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | Chan, A. and Miles, D. and Pivot, X. 2010. Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer. Annals of Oncology. 21 (12): pp. 2305-2315. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/7623 | |
| dc.publisher | Oxford University Press | |
| dc.title | Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer | |
| dc.type | Journal Article | |
| dcterms.source.volume | 21 | |
| dcterms.source.number | 12 | |
| dcterms.source.startPage | 2305 | |
| dcterms.source.endPage | 2315 | |
| dcterms.source.issn | 0923-7534 | |
| dcterms.source.title | Annals of Oncology | |
| curtin.accessStatus | Fulltext not available |